Gene therapies that could transform diseases get easier FDA path – Indianapolis Business Journal
Indianapolis Business Journal |
Gene therapies that could transform diseases get easier FDA path
Indianapolis Business Journal New therapies that could cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administration to keep pace with one of biotechnology's fastest-growing fields. Unlike … |
